A 63-year-old man was referred for cardiac evaluation after a chest radiograph for an upper respiratory tract infection demonstrated prominent mediastinal borders (Figure 1) . He had a normal clinical examination. A dilated coronary sinus was identified on transthoracic echocardiography. On subsequent transesophageal echocardiography, agitated saline contrast injected into the left antecubital vein first appeared in the coronary sinus, consistent with a persistent left-sided superior vena cava ( Figure 2A and Movie 1). Interestingly, saline injected into the right antecubital vein also first appeared in the coronary sinus ( Figure 2B and Movie 2). Imaging of the atria confirmed the absence of a right superior vena cava ( Figure 2C ). Cardiovascular MRI demonstrated that blood from the right side of the body passed via an innominate vein, anterior to the aortic arch ( Figure 3A) , to the left-sided superior vena cava ( Figure 3B and 3C and Movie 3) and then, via the dilated coronary sinus, into the right atrium ( Figure 3D and Movie 4). There was also drainage via a prominent left-sided azygos venous system ( Figure 4 ). The aorta was normal and left-sided. There was no left-to-right intracardiac shunt, and pulmonary venous drainage was normal.
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Absence of the right superior vena cava is rare. During development, blood usually passes preferentially to the rightsided cardinal venous system via a vessel between the anterior cardinal veins that becomes the left brachiocephalic vein. The left-sided veins involute to become the coronary sinus and the ligament of Marshall. In this case, the left common cardinal vein has persisted and the common and proximal anterior cardinal veins on the right have regressed. The azygos system develops from the supracardinal venous system and again usually the right-sided azygos vein is predominant with hemi-azygos and accessory hemi-azygos veins on the left. Reversal of the pattern of persistence and regression may occur if flow is restricted on the right during embryological development, similar to the mechanism described for correct patterning of the branchial arch arteries. 1 In the absence of other congenital anomalies, long-term prognosis from abnormal superior vena caval development is thought to be good, and clinical relevance relates to technical problems during pacemaker implantation, 2 insertion of central lines, and cardiopulmonary bypass. The techniques of chest radiography, transthoracic and transesophageal echocardiography, and cardiovascular MRI offered complementary approaches for diagnosis and delineation of anatomy in this case. Use of bilateral contrast injections during transesophageal imaging elegantly demonstrated absence of the right superior vena cava, whereas cardiovascular MRI provided detailed assessment of upper body venous drainage and exclusion of possible associated congenital abnormalities. 
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